Cloudian Hyperstore

Triple Threat: OnRamp Bioinformatics, Cloudian, ScaleMatrix Combine Services for Genomic Data Analysis and...

OnRamp Bioinformatics, Cloudian, ScaleMatrix Combine Services for Genomic Data Analysis and Storage Offering

Five-Year Super Successes in Genomics and Precision Medicine

Multidimensional, computationally rich approaches represent the next wave of innovation, taking personalized medicine to the next level, while demanding more of practitioners, who in...
Brain cancer, artwork

Glioblastoma Sex Differences Uncovered

It is widely appreciated that sex differences play a role in both the incidence of and treatment outcomes of many diseases, including some cancers....
Source: iStock/dra_schwartz

Invitae Expands Genetic Testing with Exome Sequencing and Interpretation Services

Invitae Boosted Exome applies NGS to analyze the exons of up to 20,000 genes, using bioinformatics solutions and interpretation.

Treading with Caution: PGx Test Developers Pursue Dialogue as FDA Maintains Enforcement Stance

Developers of pharmacogenetic tests cheered in August when United Healthcare (UHC) concluded in a policy statement effective October 1, that “the use of pharmacogenetic...
Microfluidic Single-Cell DNA Analysis

Microfluidic Single-Cell DNA Analysis

Leverages droplet microfluidics to provide high-throughput single-cell DNA with a novel two-step pro­tease workflow.
Study published in the journal of the American Academy of Ophthalmology shows that a CRISPR-based treatment can restore retinal function in mice. [Source: Shutterstock]

Genome Editing Shows Promise for Treating Eye Disease

Researchers use CRISPR gene editing technique to restore retinal function in mice afflicted with degenerative disease retinitis pigmentosa
Researchers at Keele University have developed SIFT-MS

Clinical Mass Spec Attains Critical Mass

Clinical applications for mass spectrometry technology have exploded in recent years. Mass spectrometry analysis is often faster, cheaper, and more sensitive than other methods...
Assurex Health has selected Agena Bioscience's MassARRAY® System for laboratory set-up and sample processing of its GeneSight Psychotropic test. [Agena Bioscience]

Assurex Health Selects Agena’s MassARRAY System Platform

Mass spec-based nonfluorescent detection platform chosen for lab setup and sample processing of Assurex's GeneSight Psychotropic test.
Bruker plans to acquire a majority stake in Hain Lifescience

Bruker to Expand in Infectious Disease MDx with Majority Stake in Hain

Acquisition is part of Bruker's ongoing transformation of its product portfolio to achieve faster growth, dubbed Project Accelerate
Scroll Up